[1] Baum L, Kwan P. Antiepileptic drug delivery[J]. Adv Drug Deliv Rev, 2012, 64(10):885-886.
[2] Bennewitz M F, Saltaman W M. Nanotechnology for delivery of drugs to the brain for epilepsy[J].Neurotherapeutics, 2009, 6(2):323-336.
[3] Potschka H. Role of CNS efflux drug transporters in antiepileptic drug delivery:overcoming CNS efflux drug transport[J].Adv Drug Deliv Rev, 2012, 64(10):943-952.
[4] Srivastava A K, White H S. Carbamazepine, but not valproate, displayspharmacoresistance in lamotrigine-resistantamygdala kindled rats[J].Epilepsy Res, 2013,104(1-2):26-34.
[5] Mishra B,Arya N, Tiwari S. Investigation of formulation variables affecting the properties of lamotriginenanosuspension using fractional factorial design[J]. DARU, 2010, 18(1):1-8.
[6] Soni V, Chourasia M K, Gupta Y, et al. Novel approaches for drug delivery to the brain[J]. Indian J Pharm Sci, 2004, 66(6):711-720.
[7] 李颖寰, 朱家壁,陈盛君,等. 组合小片胶囊释放行为的研究及其数学模型嵌合[J]. 药学学报,2004, 39(6):472-476.
[8] Nair R, Kumar A C, Priya V K, et al. Formulation and evaluation of chitosan solid lipidnanoparticles of carbamazepine[J].Lipids Health Dis, 2012, 11:72-79.
[9] Hsiao M H,Larsson M,Larsspon A, et al.Design and characterization of a novel amphiphilic chitosan nanocapsule-basedthermo-gelling biogel with sustained in vivo release of the hydrophilic anti-epilepsy drug ethosuximide[J].J Control Release, 2012, 161(3):942-948.
[10] 管晨峰, 路伟,张开礼,等. 载神经生长因子纳米柔性脂质体透血-脑屏障的研究[J]. 中国医药导报, 2014, 11(17):131-133.
[11] Pinzon-Daza M L,Campia I,Kopecka J, et al. Nanoparticle- and liposome-carried drugs:new strategies for active targeting and drug delivery across blood-brain barrier[J]. Curr Drug Metab, 2013, 14(6):625-640. |
